Launched at CES 2022 last week, FaceHeart Vitals SDK is an AI technology that turns tablets and smart devices into remote vital signs monitors. Available for licensing, the new software development kit uses AI algorithms to measure heart and respiratory metrics when the device camera focuses on a person’s face.
Created by FaceHeart Corporation of Taiwan, the technology expands the capabilities of the company’s FaceHeart Vitals. The platform provides tracking for activity, sleep, metabolism, equilibrium, relaxation, and overall health. FaceHeart Vitals SDK can now detect heart rate, heart rate variability, respiratory rate, blood pressure, blood oxygen level, and stress index. Users need only 60 seconds in from of the camera to record those measurements.
The software has a range of potential use cases. FaceVitals SDK data can bolster personal tracking devices to enhance workout performance and optimize personal health. For healthcare providers, the software removes barriers to remote monitoring, as it requires devices that are ubiquitous across most patient profiles. A simple solution to monitoring post-surgical patients and others recovering at home, as well as those with chronic conditions, could help reduce complications and adverse events.
In clinical trials, FaceHeart has generated 76 million datasets in clinical trials to ensure its AI functions with medical-grade accuracy. The company is pursuing FDA approval for the FaceHeart Vitals platform for use as a Software as a Medical Device (SaMD).
It should be noted that there are other camera-based monitoring platforms already on the market. We recently covered a similar SDK kit from Israeli startup Binah.ai, and consumers can download apps such as Nuralogix Anura.
Any evidence beyond HR and HRV?
Johan, I’m not clear on your question. I have been testing a different product with similar features, and it appears to be remarkably accurate at reading my blood pressure. I think that this approach has a lot of potential, since most of us carry smartphones with the camera and processing power needed to make this work.
All the best,
Alfred Poor, Editor
Health Tech Insider
Albert,
sorry but you are not a standard reference for BP accuracy validation.
I’ll trust it when a peer reviewed clinical investigation according to the BP standards is published that shows full compliance …
All the best,
Johan
Thanks for your comment, Johan, but I’m a bit puzzled. I don’t think we said anything to indicate that we validate the accuracy of this — or any other — health or medical device. All we do is report the facts as we have them, and provide an analysis to place those facts in context. In my response to you, I was simply pointing out that I do have some first-hand experience with such products. That does not mean, however, that I don’t think that validation is best left to the experts.
That’s why, in this particular article, we are careful to point out that “The company is pursuing FDA approval for the FaceHeart Vitals platform.” They do not yet have FDA clearance, but they are working toward that goal. From my perspective, this indicates that they are (1) aware of their responsibility to create a product that has valid results, and (2) are taking steps to comply with the appropriate regulatory requirements.
I hope that this clarifies our position. Let me know if you have any other questions or comments.
All the best,
Alfred Poor, Editor
Health Tech Insider